Lifeline Biotechnologies, Inc. (LLBO)
OTCMKTS · Delayed Price · Currency is USD
0.0004
-0.0002 (-33.33%)
Feb 13, 2026, 1:38 PM EST
Lifeline Biotechnologies Market Cap
Lifeline Biotechnologies has a market cap or net worth of $1.74 million as of February 13, 2026. Its market cap has increased by 33.33% in one year.
Market Cap
1.74M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 31, 2003, Lifeline Biotechnologies's market cap has decreased from 18.97M to 1.74M, a decrease of -90.83%. That is a compound annual growth rate of -10.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 1.74M | -42.86% |
| Dec 31, 2025 | 3.04M | 600.00% |
| Dec 31, 2024 | 434.89K | -35.07% |
| Dec 28, 2023 | 669.78K | -33.33% |
| Dec 30, 2022 | 1.00M | 50.00% |
| Dec 31, 2021 | 669.78K | -60.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CYduct Diagnostics | 5.14M |
| Vycor Medical | 3.67M |
| Ludwig Enterprises | 3.58M |
| AI Maverick Intel | 3.24M |
| Fuse Medical | 2.89M |
| Escalon Medical | 1.44M |
| Nu-Med Plus | 1.28M |
| St. Joseph | 1.27M |